330 related articles for article (PubMed ID: 36574293)
1. The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
Gamal W; Sahakian E; Pinilla-Ibarz J
Blood Adv; 2023 Jun; 7(11):2401-2417. PubMed ID: 36574293
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
3. The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.
Yousefi M; Movassaghpour AA; Shamsasenjan K; Ghalamfarsa G; Sadreddini S; Jadidi-Niaragh F; Hojjat-Farsangi M
Future Oncol; 2015; 11(10):1567-82. PubMed ID: 25963433
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.
Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
Leuk Lymphoma; 2015; 56(8):2424-8. PubMed ID: 25393804
[TBL] [Abstract][Full Text] [Related]
5. Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia.
Pang N; Zhang R; Li J; Zhang Z; Yuan H; Chen G; Zhao F; Wang L; Cao H; Qu J; Ding J
Int Immunopharmacol; 2016 Nov; 40():57-64. PubMed ID: 27584054
[TBL] [Abstract][Full Text] [Related]
6. Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.
Niemann CU; Herman SE; Maric I; Gomez-Rodriguez J; Biancotto A; Chang BY; Martyr S; Stetler-Stevenson M; Yuan CM; Calvo KR; Braylan RC; Valdez J; Lee YS; Wong DH; Jones J; Sun C; Marti GE; Farooqui MZ; Wiestner A
Clin Cancer Res; 2016 Apr; 22(7):1572-82. PubMed ID: 26660519
[TBL] [Abstract][Full Text] [Related]
7. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
Front Immunol; 2019; 10():2455. PubMed ID: 31681329
[TBL] [Abstract][Full Text] [Related]
8. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
Giannoni P; Cutrona G; Totero D
Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
[TBL] [Abstract][Full Text] [Related]
9. T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.
Vlachonikola E; Stamatopoulos K; Chatzidimitriou A
Front Immunol; 2020; 11():612244. PubMed ID: 33552073
[TBL] [Abstract][Full Text] [Related]
10. Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses.
Manna A; Kellett T; Aulakh S; Lewis-Tuffin LJ; Dutta N; Knutson K; Chini E; Pinilla-Ibarz J; Lamanna N; Manochakian R; Malavasi F; Sher T; Chanan-Khan AA; Ailawadhi S; Paulus A
Blood Adv; 2020 May; 4(10):2143-2157. PubMed ID: 32421811
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
[TBL] [Abstract][Full Text] [Related]
12. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J
Front Immunol; 2020; 11():590072. PubMed ID: 33329575
[TBL] [Abstract][Full Text] [Related]
13. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
14. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.
Martinez-Torres AC; Quiney C; Attout T; Boullet H; Herbi L; Vela L; Barbier S; Chateau D; Chapiro E; Nguyen-Khac F; Davi F; Le Garff-Tavernier M; Moumné R; Sarfati M; Karoyan P; Merle-Béral H; Launay P; Susin SA
PLoS Med; 2015 Mar; 12(3):e1001796. PubMed ID: 25734483
[TBL] [Abstract][Full Text] [Related]
15. Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia.
Decker T; Flohr T; Trautmann P; Aman MJ; Holter W; Majdic O; Huber C; Peschel C
Blood; 1995 Aug; 86(3):1115-23. PubMed ID: 7620165
[TBL] [Abstract][Full Text] [Related]
16. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
Van Damme M; Crompot E; Meuleman N; Maerevoet M; Mineur P; Bron D; Lagneaux L; Stamatopoulos B
Clin Epigenetics; 2016; 8():132. PubMed ID: 27980696
[TBL] [Abstract][Full Text] [Related]
17. T-lymphocyte response to cytokines in B-chronic lymphocytic leukemia.
Briggs PG; Kraft N; Atkins RC
Leuk Res; 1991; 15(9):859-65. PubMed ID: 1921461
[TBL] [Abstract][Full Text] [Related]
18. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
[TBL] [Abstract][Full Text] [Related]
19. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
Hanna BS; Öztürk S; Seiffert M
Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
[TBL] [Abstract][Full Text] [Related]
20. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
